Company Profile

KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.

Employees

133

Sector

Medical Equipment, Supplies & Distribution

More about the company

22/04	Kainos Laboratories Inc - to retire treasury shares worth 3.6% of outstanding stock on Jun 12	RE
25/03	Denka Company Limited completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders.	CI
09/02	Denka Company Limited proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders for ¥7.9 billion.	CI
09/02	Denka Unit Launches Tender Offer for Kainos Laboratories	MT
06/02	Denka Co Ltd - Will launch tender offer for Kainos shares	RE
18/12/24	Italian stationery maker FILA cuts stake in listed Indian unit DOMS	RE
14/03/22	KAINOS Laboratories, Inc. announced that it has received ¥250.47 million in funding from Sysmex Corporation	CI
25/02/22	KAINOS Laboratories, Inc. announced that it expects to receive ¥250.47 million in funding from Sysmex Corporation	CI
26/11/21	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2021.	CI
26/11/21	KAINOS Laboratories, Inc.'s Equity Buyback announced on November 25, 2021, has closed with 150,000 shares, representing 3.66% for ¥158.1 million.	CI
25/11/21	KAINOS Laboratories, Inc. announces an Equity Buyback for 150,000 shares, for ¥158.1 million.	CI
25/11/21	KAINOS Laboratories, Inc. authorizes a Buyback Plan.	CI
26/11/20	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2020.	CI

Manager	Title	Age	Since
Yukihiro Nagatsu PSD	President	67	01/04/2022
Tsukasa Hayashi ADM	Chief Administrative Officer	64	01/06/2016
Nobuaki Nakano PRN	Corporate Officer/Principal	62	01/07/2024

Director	Title	Age	Since
Yukihiro Nagatsu BRD	Director/Board Member	67	01/06/2014
Tsukasa Hayashi BRD	Director/Board Member	64	01/06/2014
Kenji Kikuchi BRD	Director/Board Member	74	01/06/2014

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KAINOS LABORATORIES, INC.	-.--%	-0.04%	-	-	62.52M
GUARDANT HEALTH, INC.	-0.80%	-0.45%	+184.50%	+495.01%	23.8B
10X GENOMICS, INC.	+0.24%	+9.63%	+680.16%	+114.47%	11.53B
BIOMÉRIEUX	-1.19%	+7.51%	-29.94%	-14.23%	10.67B
CARIS LIFE SCIENCES, INC.	-1.89%	-1.53%	+3.30%	-	8.97B
LANTHEUS HOLDINGS, INC.	-0.08%	-0.37%	+96.82%	+43.39%	6.51B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.08%	+1.06%	-27.44%	-21.96%	5.81B
DIASORIN S.P.A.	-0.98%	+3.05%	+4.25%	-9.16%	4.46B
ANDON HEALTH CO., LTD.	+1.96%	-5.39%	+56.56%	+61.68%	3.7B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.52%	+3.35%	-14.61%	-26.50%	2.9B
Average	-0.43%	+2.10%	+105.96%	+80.34%	8.71B
Weighted average by Cap.	-0.62%	+3.78%	+160.83%	+190.46%

KAINOS Laboratories, Inc. Stock

Stocks

4556

JP3205650009

Medical Equipment, Supplies & Distribution

Chart: KAINOS Laboratories, Inc.

Latest news: KAINOS Laboratories, Inc.

Managers and Directors: KAINOS Laboratories, Inc.

Diagnostic & Testing Substances

Company Profile